Use and Perceptions of Cannabidiol Products in Canada and in the United States.
Objectives: This study aimed to characterize use and perceptions of cannabidiol (CBD) products. Materials and Methods: Participants aged 16–65 years in Canada (n=15,042) and the United States (n=30,288) completed measures on prevalence and patterns of CBD product use and perceptions of CBD oil as pa...
| Publicado en: | Cannabis & Cannabinoid Research Vol. 7; no. 3; pp. 355 - 365 |
|---|---|
| Autores principales: | , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Mary Ann Liebert, Inc.
Jun2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=157306071&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 157306071 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 25785125 KS4J jtl: Cannabis & Cannabinoid Research issn: 25785125 maglogo: N pubinfo: dt: Jun2022 vid: 7 iid: 3 pid: 1365 pub: Mary Ann Liebert, Inc. place: New Rochelle, New York artinfo: ui: 157306071 157306071 157306071 10.1089/can.2020.0093 157306071 ppf: 355 ppct: 10 formats: tig: atl: Use and Perceptions of Cannabidiol Products in Canada and in the United States. aug: au: Goodman, Samantha Wadsworth, Elle Schauer, Gillian Hammond, David affil: School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada. sug: subj: Cannabidiol Therapeutic Use Cannabidiol Therapeutic Use Attitude to Medical Treatment Evaluation Human Canada United States Adolescence Young Adult Adult Middle Age Aged Descriptive Statistics Plants, Edible Food Pain Management Anxiety Drug Therapy Depression Drug Therapy Male Female Data Analysis Software Funding Source Adolescent: 13-18 years Adult: 19-44 years Middle Aged: 45-64 years Aged: 65+ years Male Female ab: Objectives: This study aimed to characterize use and perceptions of cannabidiol (CBD) products. Materials and Methods: Participants aged 16–65 years in Canada (n=15,042) and the United States (n=30,288) completed measures on prevalence and patterns of CBD product use and perceptions of CBD oil as part of the 2019 International Cannabis Policy Study online survey. Results: Past 12-month CBD product use was significantly more prevalent among respondents in the United States (26.1%) than in Canada (16.2%). Consumers in the United States and Canada reported using a range of CBD products, including drops (46.3% vs. 47.3%, respectively), topicals (26.0% vs. 16.7%), edibles/foods (23.8% vs. 17.6%), vape oils (18.9% vs. 13.3%), capsules (13.3% vs. 16.7%), and dried flower (10.1% vs. 16.1%). CBD was most commonly reported for management of pain, anxiety, and depression. Over half of CBD consumers in both countries reported that CBD oil was beneficial for health. Conclusions: Use of CBD products is common in both the United States and Canada, primarily to manage self-reported health conditions for which there is little or no evidence of efficacy. Clearer public health messaging regarding the therapeutic effects of CBD is warranted. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|